Your shopping cart is currently empty

Carbonic anhydrase activator 1 (Compound 17) is an orally active compound capable of penetrating the blood-brain barrier (BBB), and acts as an activator of carbonic anhydrase (CA). It exhibits KA values of 7.8 μM for hCA I, 3.9 μM for hCA VA, and 2.1 μM for hCA VII. Carbonic anhydrase activator 1 is applicable to research in cancer, glaucoma, cardiovascular diseases, and neurodegenerative disorders such as epilepsy.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | Carbonic anhydrase activator 1 (Compound 17) is an orally active compound capable of penetrating the blood-brain barrier (BBB), and acts as an activator of carbonic anhydrase (CA). It exhibits KA values of 7.8 μM for hCA I, 3.9 μM for hCA VA, and 2.1 μM for hCA VII. Carbonic anhydrase activator 1 is applicable to research in cancer, glaucoma, cardiovascular diseases, and neurodegenerative disorders such as epilepsy. |
| Targets&IC50 | CA I (human):7.8 μM (KA) |
| Molecular Weight | 333.37 |
| Formula | C17H11N5OS |
| Cas No. | 2374923-30-3 |
| Smiles | N#CC1=C(N=C(N)C(C#N)=C1C=2OC=CC2)SCC=3C=CN=CC3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.